DEVELOPMENT SITE ONLY
Please use current guidelines available on the UHNM intranet for patient treatment
Please use current guidelines available on the UHNM intranet for patient treatment
RECOGNITION
- Vitamin deficiency usually develops slowly over several months to years
- Vitamin deficiency signs and symptoms may be subtle at first
- increase as the deficiency worsens
Symptoms
Neurological
- Numbness or paraesthesia
- Muscle weakness
- Unsteady movements
Megaloblastic anaemia
- Breathlessness
- Fatigue
- Dizziness
Non-specific
- Memory loss
- Personality changes
- Mental confusion or forgetfulness
- Irregular heartbeats
Signs
- Pale or yellowish skin
- Glossitis
- Peripheral neuropathy
- especially proprioception
- Sub-acute combined degeneration of the cord
- which may occur in the absence of anaemia
Assessment
- Diet
- Features of malabsorption
- Personal/FH of autoimmune conditions
- GI surgery
- Medication use
- e.g. proton pump inhibitors, metformin, OCP
- Pregnancy and OCP
- oestrogen reduces serum B12 (but not functional B12)
- by 25% on oral contraceptive pill
- by <30% by third trimester of pregnancy
- level >150 pg/mL may therefore be normal
Investigations
- FBC
- Folate
- Serum cobalamin (B12)
- Anti-intrinsic factor Ab (anti-IF Ab)
- if suspect PA, test for anti-IFAB regardless of cobalamin levels
INITIAL MANAGEMENT
Pancytopenia
Refer to haematology
Symptoms/signs of B12 deficiency present
B12 low but symptoms/signs absent
- B12 ≤200 pg/mL
- Non-specific symptoms
TREATMENT
Pernicious anaemia
- Prescribe vitamin B12 as hydroxocobalamin
- Treatment regimens are dependent on symptoms/signs. See BNF
Dietary cause
- Dietary sources of B12 include eggs, milk/dairy products, salmon, fortified products e.g. cereals
- In the absence of neuropathy, consider oral cyanocobalamin 50-150 microgram daily taken between meals (although higher doses may be required)
- check B12 levels at 1-3 months
- Duration of B12 supplementation depends on the cause of the deficiency and response
- When using oral cyanocobalamin, caution regarding possible emerging PA
RBC transfusion in chronic anaemia
- If severe symptoms of anaemia, discuss with haematology before initiating transfusion which is rarely required
ASSESSING RESPONSE
- If patient receiving IM hydroxocobalamin, do not routinely check B12 levels
- Monitor for hypokalaemia after commencing B12 replacement and consider replacement
- If PA, assess reticulocyte response at 7-10 days
- suboptimal response may indicate concomitant iron deficiency
DISCHARGE
- Inform GP of:
- cause
- treatment
- monitoring required